Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Sharon Rosenzweig‐Lipson"'
Publikováno v:
Neurotherapeutics, Vol 21, Iss 4, Pp e00395- (2024)
Externí odkaz:
https://doaj.org/article/22b17bc45d21488c891213390f557c3c
Autor:
Richard Mohs, Arnold Bakker, Sharon Rosenzweig‐Lipson, Michael Rosenblum, Russell L. Barton, Marilyn S. Albert, Sharon Cohen, Scott Zeger, Michela Gallagher
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 10, Iss 1, Pp n/a-n/a (2024)
Abstract INTRODUCTION In addition to the accumulation of amyloid plaques and neurofibrillary tangles, the presence of excess neural activity is a pathological hallmark of Alzheimer's disease (AD) and a prognostic indicator for progression of AD patho
Externí odkaz:
https://doaj.org/article/42aaa9d7842c4b72aeecc5f9cb9624d9
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 02/13/2023.
Publikováno v:
Clinical Trials Week; 2/27/2023, p827-827, 1p
Publikováno v:
Alzheimer's & Dementia. 17
Autor:
Chris J. Edgar, Michela Gallagher, Russell Barton, Sharon Rosenzweig-Lipson, Richard C. Mohs, Paul Maruff
Publikováno v:
Alzheimer's & Dementia. 16
Publikováno v:
Schizophrenia Research. 193:119-125
Imbalance in neural excitation and inhibition is associated with behavioral dysfunction in individuals with schizophrenia and at risk for this illness. We examined whether targeting increased neural activity with the antiepileptic agent, levetiraceta
Autor:
Michael J. Detke, Sharon Rosenzweig-Lipson, Janet B. W. Williams, Earl L. Giller, John M. Kane, Joan H.Q. Shen, Danielle Popp, Yonggang Zhao
Publikováno v:
Journal of Psychiatric Research. 53:14-22
Vabicaserin, a potent 5-HT2C receptor agonist, decreases nucleus accumbens extracellular dopamine levels in rats, without affecting striatal dopamine, indicating mesolimbic selectivity. This is the first study of efficacy, safety and tolerability of
Autor:
Sarah J. Neal, M. Olsen, Sharon Rosenzweig-Lipson, S.K. Leonard, Zoë A. Hughes, Deborah L. Smith, Robert H. Ring, Stacey J. Sukoff Rizzo, T.H. Andree, John Dunlop, Susan M. Lotarski, C.M. Pulicicchio, Lee E. Schechter, Dane Springer, Shendi Lu, Jason M. Dwyer, Garth T. Whiteside, E. Kouranova, J.E. Harrison, Julie A. Brennan, Steven Victor O'neil, C.N. Bender
Publikováno v:
Neuropharmacology. 66:202-214
Evidence suggests that 30–50% of patients suffering from major depressive disorder (MDD) are classified as suffering from treatment resistant depression (TRD) as they have an inadequate response to standard antidepressants. A key feature of this pa
Autor:
Sharon Rosenzweig-Lipson, Kenner C. Rice, Noelle C. Anastasio, Marcy J. Bubar, Cheryl S. Watson, F. Gerard Moeller, Sarah E. Swinford, Sonja J. Stutz, Kathryn A. Cunningham, Robert G. Fox, Scott R. Gilbertson
Publikováno v:
ACS Chemical Neuroscience. 4:110-121
Relapse to cocaine dependence, even after extended abstinence, involves a number of liability factors including impulsivity (predisposition toward rapid, unplanned reactions to stimuli without regard to negative consequences) and cue reactivity (sens